home
products
support
blog
about
login
login
signup
Home
anpa@simplelists.com
Fwd: FDA Issues Emergency Use Authorization For Monoclonal Antibody Combination For Patients With Mild To Moderate SARS-CoV-2 At Risk For Severe COVID-19
Archive index
By thread
By date
Fwd: FDA Issues Emergency Use Authorization For Monoclonal Antibody Combination For Patients With Mild To Moderate SARS-CoV-2 At Risk For Severe COVID-19
Gertie Chimeka Anyanwoke
11 Feb 2021 09:26 CST